SCHEMBL2279660

SCHEMBL2279660

O=C(O)Cc1c(-c2ccccc2)noc1-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 8/20 0.54
NR4A1 P22736 2/20 0.54
NR4A3 Q92570 2/20 0.54
PTGS1 P23219 3/20 0.51
PPARD Q03181 2/20 0.46
NR1H4 Q96RI1 1/20 0.46
PTPN1 P18031 1/20 0.46
FFAR4 Q5NUL3 1/20 0.45
RXRA P19793 3/20 0.44
RXRB P28702 3/20 0.44
KDM4E B2RXH2 2/20 0.44
RXRG P48443 2/20 0.44
ABCC4 O15439 2/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 2/20 0.44
C5 P01031 1/20 0.44
CHRM2 P08172 1/20 0.44
CYP3A4 P08684 1/20 0.44
CHRM1 P11229 1/20 0.44
DRD2 P14416 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22769599 0.84 PTGS1 (0.50) NR4A2NR4A1NR4A3PTGS1PTPN1
SCHEMBL5774112 0.84 RXRA (0.56) NR4A2NR4A1NR4A3PTGS1PPARD
SCHEMBL12406914 0.83 PTGS1 (0.59) NR4A2NR4A1NR4A3PTGS1PPARD
SCHEMBL11897018 0.82 SMN1; SMN2 (0.49) NR4A2NR4A1NR4A3PTGS1PTPN1
SCHEMBL27495332 0.82 ALDH1A1 (0.59) PTGS1KDM4ETSHRPTGS2ALDH1A1
SCHEMBL2278944 0.82 PPARD (0.42) NR4A2NR4A1NR4A3PTGS1PPARD
SCHEMBL31526337 0.81 PTGS1 (0.47) PTGS1PTPN1FFAR4PTGS2ALDH1A1
SCHEMBL27749854 0.80 PTGS2 (0.58) NR4A2NR4A1NR4A3PTGS1PPARD
SCHEMBL22769587 0.76 PTGS1 (0.48) NR4A2NR4A1NR4A3PTGS1FFAR4
SCHEMBL22769588 0.74 HDAC1 (0.54) NR4A2PTGS1FFAR4RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989450-B2 Functionalized diarylisoxazoles inhibitors of ciclooxygenase UNIVERSITA' DEGLI STUDI DI BARI (IT) 2011-08-02 US disclosed
US-20090181970-A1 Functionalized diarylisoxazoles inhibitors of ciclooxygenase UNIVERSITA' DEGLI STUDI DI BARI (IT) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181970-A1 Functionalized diarylisoxazoles inhibitors of ciclooxygenase PTGIS, ALOX5, ALOX15 NR4A2 3206/4885NR4A1 2510/4885NR4A3 2583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.